These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36159555)

  • 1. Overexpression of SRD5A3 in Hepatocellular Carcinoma and Its Molecular Mechanism: A Study of Bioinformatics Exploration Analysis with Experimental Verification.
    Chen E; Yi J; Ren Q; Mi Y; Gan Z; Liu J
    Evid Based Complement Alternat Med; 2022; 2022():7853168. PubMed ID: 36159555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid 5 alpha-reductase 3 (SRD5A3) promotes tumor growth and predicts poor survival of human hepatocellular carcinoma (HCC).
    Mai Q; Sheng D; Chen C; Gou Q; Chen M; Huang X; Yin H; Chen X; Chen Z
    Aging (Albany NY); 2020 Nov; 12(24):25395-25411. PubMed ID: 33229626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDT1 Is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma.
    Cai C; Zhang Y; Hu X; Hu W; Yang S; Qiu H; Chu T
    Front Oncol; 2021; 11():721644. PubMed ID: 34631549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic biomarker SMARCC1 and its association with immune infiltrates in hepatocellular carcinoma.
    Cai X; Zhou J; Deng J; Chen Z
    Cancer Cell Int; 2021 Dec; 21(1):701. PubMed ID: 34937564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune infiltration-associated serum amyloid A1 predicts favorable prognosis for hepatocellular carcinoma.
    Zhang W; Kong HF; Gao XD; Dong Z; Lu Y; Huang JG; Li H; Yang YP
    World J Gastroenterol; 2020 Sep; 26(35):5287-5301. PubMed ID: 32994688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression and prognostic value of GLYATL1 and its potential role in hepatocellular carcinoma.
    Guan R; Hong W; Huang J; Peng T; Zhao Z; Lin Y; Yu M; Jian Z
    J Gastrointest Oncol; 2020 Dec; 11(6):1305-1321. PubMed ID: 33457003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein].
    Wang XJ; Shen RF; Wang X; Wang YR; Xiao T
    Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):396-402. PubMed ID: 32482029
    [No Abstract]   [Full Text] [Related]  

  • 8. Over-expression of SRD5A3 and its prognostic significance in breast cancer.
    Zhang YP; Na WT; Dai XQ; Li RF; Wang JX; Gao T; Zhang WB; Xiang C
    World J Surg Oncol; 2021 Aug; 19(1):260. PubMed ID: 34465365
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Liu S; Zhao W; Li X; Zhang L; Gao Y; Peng Q; Du C; Jiang N
    Front Oncol; 2021; 11():713017. PubMed ID: 34595113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of CISD1 Predicts Worse Survival in Hepatocarcinoma Patients.
    Lu T; Li C; Xiang C; Gong Y; Peng W; Chen C
    Biomed Res Int; 2022; 2022():7823191. PubMed ID: 35313629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Centromere Protein F (
    Huang Y; Chen X; Wang L; Wang T; Tang X; Su X
    J Cancer; 2021; 12(10):2933-2951. PubMed ID: 33854594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential Role of NEU1 in Hepatocellular Carcinoma: A Study Based on Comprehensive Bioinformatical Analysis.
    Wu Z; He L; Yang L; Fang X; Peng L
    Front Mol Biosci; 2021; 8():651525. PubMed ID: 34513919
    [No Abstract]   [Full Text] [Related]  

  • 13. Hamster SRD5A3 lacks steroid 5α-reductase activity in vitro.
    Chávez B; Ramos L; García-Becerra R; Vilchis F
    Steroids; 2015 Feb; 94():41-50. PubMed ID: 25498908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
    Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
    World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leucine zipper downregulated in cancer 1 may serve as a favorable prognostic biomarker by influencing proliferation, colony formation, cell cycle, apoptosis, and migration ability in hepatocellular carcinoma.
    Chen H; Chen S; Chen C; Li A; Wei Z
    Front Genet; 2022; 13():900951. PubMed ID: 35957693
    [No Abstract]   [Full Text] [Related]  

  • 16. Integrative bioinformatics and experimental analysis revealed TEAD as novel prognostic target for hepatocellular carcinoma and its roles in ferroptosis regulation.
    Ren X; Wang X; Yan Y; Chen X; Cai Y; Liang Q; Peng B; Xu Z; He Q; Kang F; Li J; Zhang W; Hong Q; Peng J; Xiao M
    Aging (Albany NY); 2022 Jan; 14(2):961-974. PubMed ID: 35077390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
    Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
    BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prognostic Value of AT-Rich Interaction Domain (ARID) Family Members in Patients with Hepatocellular Carcinoma.
    Li S; Wu Z; Li Q; Liang Q; Zhou H; Shi Y; Zhang R; Pan H
    Evid Based Complement Alternat Med; 2022; 2022():1150390. PubMed ID: 36034939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
    Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
    Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.